Diagnostic and prognostic performance of CSF α‐synuclein in prion disease in the context of rapidly progressive dementia
Open Access
- 1 January 2021
- journal article
- research article
- Published by Wiley in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
- Vol. 13 (1) , e12214
Abstract
Introduction: Surrogate cerebrospinal fluid (CSF) biomarkers of neurodegeneration still have a central role in the first‐line screening of patients with suspected Creutzfeldt‐Jakob disease (CJD). Recently, CSF α‐synuclein, a marker of synaptic damage, showed a close to optimal performance in distinguishing between CJD and other neurodegenerative dementias. Methods: We evaluated the diagnostic value of CSF α‐synuclein in patients with prion disease, non‐prion rapidly progressive dementias, and non‐neurodegenerative controls. Additionally, we studied its distribution across the different prion disease subtypes and evaluated its association with survival. Results: CSF α‐synuclein levels were significantly higher in patients with prion disease than in the other groups but showed a lower diagnostic value than CSF total tau or 14‐3‐3. Moreover, CSF α‐synuclein was significantly associated with survival in the whole prion cohort and the most frequent clinicopathological subtypes. Discussion: In the clinical setting, CSF α‐synuclein does not exceed the diagnostic performance of currently used surrogate markers, but it might constitute a robust prognostic indicator.Keywords
This publication has 30 references indexed in Scilit:
- Sporadic Creutzfeldt–Jakob disease diagnostic accuracy is improved by a new CSF ELISA 14-3-3γ assayNeuroscience, 2016
- Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt–Jakob disease and rapid dementias: a longitudinal multicentre study over 10 yearsBrain, 2012
- A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob diseaseNeurology, 2012
- Real time quaking‐induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt–Jakob diseaseAnnals of Neurology, 2012
- Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementiasNeurology, 2011
- Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversionNature Medicine, 2011
- Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosisJournal of Neurology, 2007
- Snaring the Function of α-SynucleinCell, 2005
- Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjectsAnnals of Neurology, 1999
- Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects.1999